UnknownPhase 2NCT02000960
Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
Studying Classic glucose transporter type 1 deficiency syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of British Columbia
- Principal Investigator
- Sylvia StocklerThe University of British Columbia/BC Children's Hospital
- Intervention
- Triheptanoin(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 1-18 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- BC Children's Hospital, Vancouver, British Columbia, Canada
Collaborators
Ultragenyx Pharmaceutical Inc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02000960 on ClinicalTrials.govOther trials for Classic glucose transporter type 1 deficiency syndrome
Additional recruiting or active studies for the same condition.
See all trials for Classic glucose transporter type 1 deficiency syndrome →